Cancer Screening, Surrogates of Survival, and the Soma.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Screening leads to meaningful reductions in deaths from cancers. However, reductions in all-cause mortality (ACM) are harder to demonstrate. Failure to demonstrate ACM benefit should not diminish advances in cancer screening. We consider how co-morbidities related to an aging and damaged soma can hinder achievement of ACM benefit.
Description
Journal Title
Cancer Cell
Conference Name
Journal ISSN
1535-6108
1878-3686
1878-3686
Volume Title
38
Publisher
Cell Press
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International